Gilead Sciences CEO Stepping Down

John Milligan will also depart from the board of directors at the end of the year

Updated July 25, 2018 6:53 p.m. E

Gilead Sciences Inc. Chief Executive Officer John Milligan will step down at the end of the year, an abrupt departure from a drug company struggling with falling sales and profit.

https://www.wsj.com/articles/gilead-sciences-ceo-steps-down-1532550673?mod=nwsrl_small_business&cx_refModule=nwsrl